How the FDA regulates compounding pharmacies

April 5, 2015- Interviewed by Steven E. Greer, MD

Few people knew what a compounding pharmacy was until a meningitis outbreak traced to the New England Compounding Pharmacy made the news in 2012. The facility was filthy, unregulated, and Read more »

When Bad Doctors Happen to Good Patients

August 31, 2015- The NYT has an Op-Ed today by some malpractice lawyers urging a new law to be passed in New York to expand the time frame for filing malpractice suits. Read more »

Can a “calculator” really tell doctors who should be on Lipitor?

November 13, 2013- By Steven E. Greer, MD

The AHA released the long-awaited new guidelines that recommend which patients should be on a cholesterol-lowering statin, such as Lipitor or Crestor. The panel of experts incorporated evidence-based medicine into the guidelines, perhaps better than any other medical society guideline panel has done previously. However, the panel also used some very dubious statistical tools as well.

According to Read more »

The Deans of Johns Hopkins and Miami discuss ACO’s

By Steven Greer, MD

Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations, or ACO’s. The new ACA healthcare law will mandate academic medical centers to form new groups of doctors and Read more »

How did a small academic lab succeed where big medical device companies failed?

July 5, 2014- Interviewed by Steven E. Greer, MD

The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas” being developed by engineers at Boston University and medical doctors at Massachusetts General hospital. We interviewed Ed Damiano, PhD, the lead biomedical engineer, and Steven Russell, MD PhD, the lead endocrinologist.

In Part 3, we asked them how their small lab funded only by the NIH succeeded at developing the bionic pancreas when large companies, such as Roche, Medtronic, Abbott, and JNJ all failed.

Senator Angus King discusses his bill to make medical device pricing transparent to the public

July 9, 2014- Interviewed by Steven E. Greer, MD

Senator Angus King from Maine has proposed a a bill that would make the pricing of medical devices more transparent. Currently, hospitals are required to sign confidentiality agreements, and the market is entirely in the dark. If such a law were passed, it would turn the medical device industry on its head.

How to handle a defamatory online review of your medical practice

 August 13, 2015- By Steven E. Greer, MD

I still have active medical licenses, but only treat friends and family. I have no office and no “practice” to speak of. Therefore, I found it quite odd that the online doctor-shopping Read more »

Senator Grassley discusses the NIH and industry bias

High fructose consumption and fatty liver disease

Interviewed by Steven E. Greer, MD

In 1080iHD full screen for better viewing of data graphs

Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology discusses a paper she co-authored investigating the effects on the liver of high levels of fructose typical of the American diet. The study compared the effects to glucose. The study suggests that fructose causes more fatty liver disease than other sugars.

This is a timely publication given the recent New York City ban on single serving sizes of sugary drinks that exceed 16-ounces, and builds on the body of literature supporting that regulation.

Doctors complain to Columbia about Dr. Oz

Update April 21, 2015- By Steven E. Greer, MD

As a direct result of our posting of the letter, below, the New York Times then national TV news have picked up this story. The bad press forced Dr. Oz to make a statement on his TV show that he “Will not be Read more »